Fenticonazole
Indications
Registered South African indications:
- Vulvovaginal candidiasis
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hypersensitivity to the imidazole derivatives
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
- Concomitant use of barrier contraceptives
Adult dosage
Forms avail. in SA and in this monograph: cre, ovule
Vulvovaginal candidiasis
- Topical (cre): 5g, applied intravaginally, morning and night; Treatment duration: 3 days
- Topical (ovule): 200mg, intravaginally, dly at night; Treatment duration: 3 days
OR - Topical (ovule) 600mg, as single dose, at night
Sexual partner should also be treated
Paediatric dosage
Not established for use in children
Special populations
Pregnancy
- Caution
- Oral administration of fenticonazole in rats has been reported to produce prolonged gestation and embryotoxic effects after doses above 40mg/kg/day. Fenticonazole does not interfere with the function of male and female gonads and does not modify the first phases of reproduction
- Fenticonazole has shown no teratogenic effects in rats and rabbits. Fenticonazole or its metabolites cross the placental barrier in pregnant rats and rabbits after vaginal application
- Since there is no experience of use during pregnancy, fenticonazole should not be used unless considered essential to the welfare of the patient
- Pregnant women should not use an applicator without medical instruction
Breastfeeding
- Caution
- Since there is no experience of use during breastfeeding, fenticonazole should not be used by breastfeeding mothers unless it is considered essential to the welfare of the patient
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Genitourinary Disorders
- Transient vaginal burning
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
Interactions
No information available
Monitoring
None routine
Mechanism of action
Fenticonazole is a potent broad spectrum antimycotic agent. The mechanism of action of fenticonazole is thought to be the blocking of oxidant enzymes with accumulation of peroxides and necrosis of the fungal cell; direct action on the membrane.
Dosage forms
- Vaginal cream
- Vaginal tablet
Formulation
Vaginal cream (per 5g) 100mg
- Lomexin (Litha Pharma) originator
Vaginal ovules 200mg
- Lomexin (Litha Pharma) originator
Vaginal ovules 600mg
- Lomexin (Litha Pharma) originator
References
1. SAMF_12th Edition_Page 218 2. SmPC: Gynoxin 2% vaginal cream, Recordati Pharmaceuticals Limited:Last updated on eMC: 21 Oct 2010; Downloaded online 20 Feb 2019 [https://www.medicines.org.uk/emc/medicine/23833] 3. SmPC: Gynoxin 600 mg vaginal capsules, Recordati Pharmaceuticals Limited:Last updated on eMC: 21 Oct 2010; Downloaded online 20 Feb 2019 [https://www.medicines.org.uk/emc/medicine/23831] 4. PI: Lomexin vaginalcream/200mg vaginal ovules/600mg vaginal ovules, Pharmaplan Pty Ltd:Date of registration: 14 Aug 2009 [https://drive.google.com/drive/folders/0B0xnChtF7vdubWJ3d3hzOGFvYkE] 5. NAPOS: The Drug Database for Acute Porphyria: Fenticonazole; Accessed online 20 Feb 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=G01AF12&l=gbr] 6. South African Institute for Drug-Free Sport: Lomexin; Accessed online 20 Feb 2019 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
3 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldVcrGeneric· 1 product
from R11.16/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Lomexin | 100 mg/5g | 30 | S3 | R334.87 | R11.16 | R117.33 | 833908006 |
vaginal creamGeneric· 2 products
from R111.62/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Lomexin | 200 mg | 3 | S3 | R334.87 | R111.62 | R117.33 | 833916009 |
| Lomexin | 600 mg | 1 | S3 | R334.87 | R334.87 | R117.33 | 833924001 |
- Lomexin
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.